Doctor Discussion Guide
Doctor Discussion Guide
Doctor Discussion Guide Be prepared to talk with a doctor about CPP and your child. Take our Doctor Discussion Guide with you to your pediatrician visit to help you get the answers you need.
Appointment Reminder
Appointment Reminder
Appointment Reminder Getting regular injections of Lupron Depot-PED is important to the success of your child's therapy. Never forget a doctor appointment with our email Appointment Reminder.
About Lupron Depot-PED
 Log In

Understanding Your Child's Treatment

The body changes that are associated with puberty occur too soon in children with central precocious puberty (CPP). Fortunately Lupron Depot-PED is available to help. Understanding how Lupron Depot-PED works to stop the body changes related to CPP is an important part of getting your child the treatment he or she needs. The more you know about CPP and its treatment, the better equipped you will be to work with your child's doctor.

How Lupron Depot-PED Works

Lupron Depot-PED belongs to a class of drugs called gonadotropin-releasing hormone agonists (GnRHa), synthetic versions of a naturally occurring hormone, GnRH. Lupron Depot-PED works in children by stopping the production of these hormones at adult levels. Stopping the production of these hormones until a more appropriate time in your child's life delays puberty.

Dosage

Lupron Depot-PED is administered as an injection on a monthly basis. The dose and duration of treatment is individualized for each patient. Discontinuation of Lupron Depot-PED should be considered before age 11 for girls and age 12 for boys.

Read on to learn more about what you and your child can expect during treatment with Lupron Depot-PED.

To read complete Product Information, click here.
See below for important safety and other information on Lupron Depot-PED.
All photos are of models and not of users of Lupron Depot-PED or persons suffering symptoms described.
    

Important Safety and Other Information:

Lupron Depot-PED (7.5 mg, 11.25 mg, and 15 mg) is used for the treatment of central precocious puberty. In clinical studies, the most frequent adverse event related to therapy with Lupron Depot-PED was an injection site reaction, seen in 5% of children in the combined studies. The recommended starting dose of Lupron Depot-PED is 0.3 mg/kg/4 weeks (minimum 7.5 mg). Inadequate dosing may result in poor control of the pubertal process.

For further information about Lupron Depot-PED, please see the complete Prescribing Information, as well as the
Patient Product Information.
  
©2005, 2008 Abbott Laboratories, Abbott Park, Illinois, U.S.A.